Neurodegenerative conditions arise from a combination of genetic vulnerabilities, inflammation, oxidative stress, impaired detoxification, mitochondrial weakness, vascular changes, and long-term stress on the nervous system. Using Lifecode Gx analysis, I work with the key pathways that influence these conditions, including APOE, MTHFR, COMT, MAOA, MAOB, BDNF, the dopamine receptors DRD2, DRD3 and DRD4, and the neurotransmitter transporters SLC6A2, SLC6A3 and SLC6A4. These reveal how effectively the brain manages dopamine, serotonin and noradrenaline, adapts to stress, repairs neuronal damage and maintains cognitive flexibility.

I also explore the major inflammatory genes IFNG, TNF and IL6, and the antioxidant and glutathione genes SOD2, GPX, NQO1 and the wider glutathione system, which together protect the brain from oxidative injury and metabolic stress. These pathways are central in the development of Alzheimer’s disease, Parkinson’s disease and vascular dementia.

Parkinson’s in particular often begins in the gut, where disrupted digestion, microbiome imbalance and chronic inflammation can trigger alpha-synuclein misfolding that slowly travels along the vagus nerve into the brain. This gut–brain connection is a significant part of my assessment and therapeutic process.

I combine these genetic insights with functional medicine, nutritional and metabolic optimisation, cardiovascular support, gut-brain healing, targeted supplementation, lifestyle interventions and gentle homeoherbal medicine. My aim is to strengthen the brain’s resilience long before symptoms appear, reduce vascular and inflammatory burden, support mitochondrial health, and create the conditions for long-term cognitive clarity and emotional stability.